This project will evaluate the superiority of a combination therapy against signaling pathways maintaining the tumor as a cellular organ in a model for providing the rationale for a clinical trial.
AI recognizes an increase in insulin demand and increase in body temperature.?? This leads to a lower risk of getting infected and reduces the severity of the disease.
Implandata is going to transform glaucoma care via its disruptive Eyemate system for digitally enabled remote management of glaucoma patients
Developing a smart innovative inhalable nanosystem for treatment of non-small cell lung cancer
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.